
The Office of Prescription Drug Promotion issues all-time low number of violation letters in 2015.
Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

The Office of Prescription Drug Promotion issues all-time low number of violation letters in 2015.

FDA discusses a new program that allows pharmaceutical companies to submit proposals for new manufacturing technology.

The National Institutes of Health released a strategic plan covering the fiscal years 2016-2020.

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc., was arrested on Dec. 17, 2015 at his apartment in New York City for securities fraud.According to a press release from the Eastern District of New York State Attorney’s Office, a seven-count indictment was unsealed on Dec. 17, 2015 in federal court in Brooklyn charging Shkreli with securities fraud, securities fraud conspiracy, and wire fraud conspiracy.

Sanofi Pasteur was granted marketing authorization for Dengvaxia, the first vaccine for dengue fever.

Express Scripts announced its plan to offer a $1 alternative to Daraprim, a generic drug used for the treatment of toxoplasmosis.

The Committee on Energy and Commerce met to assess influenza vaccine effectiveness, and changes for the 2015-2016 season.

Lawsuit alleges birth control packaging error led to 113 unwanted pregnancies.